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Abstract
Epimorphin modulates epithelial morphogenesis in embryonic mouse organs. We previously
suggested that epimorphin contributes to repair of bleomycin-induced pulmonary fibrosis in mice
via epithelium-mesenchyme interactions. To clarify the role of epimorphin in human lungs, we
evaluated epimorphin expression and localization in normal lungs, lungs with nonspecific interstitial
pneumonia (NSIP), and lungs with usual interstitial pneumonia (UIP); we also studied the effect of
recombinant epimorphin on cultured human alveolar epithelial cells in vitro. Northern and Western
blotting analyses revealed that epimorphin expression in NSIP samples were significantly higher
than those in control lungs and lungs with UIP. Immunohistochemistry showed strong epimorphin
expression in mesenchymal cells of early fibrotic lesions and localization of epimorphin protein on
mesenchymal cells and extracellular matrix of early fibrotic lesions in the nonspecific interstitial
pneumonia group. Double-labeled fluorescent images revealed expression of matrix
metalloproteinase 2 in re-epithelialized cells overlying epimorphin-positive early fibrotic lesions.
Immunohistochemistry and metalloproteinase activity assay demonstrated augmented expression
of metalloproteinase induced by recombinant epimorphin in human alveolar epithelial cells. These
findings suggest that epimorphin contributes to repair of pulmonary fibrosis in nonspecific
interstitial pneumonia, perhaps partly by inducing expression of matrix metalloproteinase 2, which
is an important proteolytic factor in lung remodeling.
Introduction
Fetal development and morphogenesis of various tissues
and organs such as hair follicles, teeth, salivary glands,
mammary glands, kidneys, liver, pancreas, and lungs
depend on epithelium-mesenchyme interactions [1,2].
Such interactions are believed to be important for the tis-
sue regeneration necessary for wound healing in adults
[3]. Pulmonary fibrosis is thought to be a result of wound
healing or regeneration after lung injury [4-11]. Lung
injury causes the epithelial basement membrane to be
destroyed, which enables migration of interstitial cells
into intra-alveolar spaces where they produce and deposit
extracellular matrix (ECM). Regenerated epithelial cells
then cover the surface of the intra-alveolar fibrotic area. If
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the injury is mild and focal and re-epithelialization has
occurred, these epithelial cells appear widespread over
early intraluminal fibrotic lesions and form intra-alveolar
buds, which later become small collagen globules and do
not contribute to alveolar structural remodeling [5-7,9-
13]. For example, intra-alveolar buds, in a so-called organ-
izing pneumonia pattern, are frequently observed in non-
specific interstitial pneumonia (NSIP); NSIP usually has a
better prognosis than does usual interstitial pneumonia
(UIP), which has fibroblastic foci without good re-epithe-
lialization [8-10,13,14] as early fibrotic lesions. The re-
epithelialization around early fibrotic lesions is similar to
the process of fetal epithelial development [4-7], which
suggests that epithelium-mesenchyme interactions may
play a key role in repair of pulmonary fibrosis.
Epimorphin is a mesenchymal cell surface-associated pro-
tein that modulates epithelial morphogenesis in embry-
onic mouse organs including lungs and skin [15].
Epimorphin expression was found in fetal lungs and skin
rudimentary cells, at the mesenchyme-epithelium inter-
face. Epimorphin also directs epithelial morphogenetic
processes in other gastrointestinal organs and mammary
glands [15-21]. For example, primary cultured rat hepato-
cytes (an epithelial cell) were used to show that epimor-
phin induces formation of hepatocyte spheroids with a
bile canaliculi-like structure, which maintained albumin
production even without growth factors [16]. Epimorphin
mediated mammary luminal morphogenesis by control-
ling expression of CCAAT/enhancer binding protein β
[22], which is essential for proper mammary morphogen-
esis and for determination of the fate of mammary epithe-
lial cells [23].
In cultured mammary epithelial cells, epimorphin aug-
mented expression of matrix metalloproteinase 2 (MMP-
2), an important proteinase in matrix degradation, and
both epimorphin and MMP-2 were required for mam-
mary gland morphogenesis [24]. During fetal rabbit lung
development, MMP-2 and MT1-MMP (an activator of
MMP-2) were detected in epithelial cells, and expression
of active MMP-2 and MT1-MMP increased dramatically;
MMP-2 and MT1-MMP were especially predominant dur-
ing late development, in which there was an extremely
wide alveolar surface, which indicated an important role
for MMP-2 in alveoli formation [25]. MMP-2 was also up-
regulated and activated in regenerated alveolar epithelial
cells, which may lead to elongation and migration of
these cells for repair of pulmonary fibrosis [26,27].
The epimorphin gene is highly conserved among mouse,
rat, and human [15,28]: the 289 amino acid sequence of
rat epimorphin/syntaxin 2 exhibits 86% homology to
human epimorphin [29]. However, the distribution and
function of epimorphin in human lungs, including during
fibrosis, are unknown. To clarify the role of epimorphin in
human lungs, especially in fibrosis, we evaluated epimor-
phin expression and localization in normal control lungs
and in lungs affected by NSIP or UIP, especially in early
intra-alveolar fibrotic lesions. We also used cultured
human alveolar epithelial cells to assess the effect of
recombinant epimorphin on MMP-2 expression.
Materials and Methods
Patients
All histologic slides from open or thoracoscopic lung
biopsies in the files of the Department of Pathology,
Kumamoto University Hospital, from 2000 to 2003, were
evaluated. From among these samples, 17 patients were
selected, with 8 fulfilling the histologic and clinical crite-
ria for NSIP and 9 showing UIP. To confirm the histologic
diagnosis, two pulmonary pathologists reviewed the
slides; they were informed only of the age and sex of each
patient and the presence of bilateral pulmonary disease
determined by chest posteroanterior radiography and
high-resolution computed tomography. All patients had
had no steroid therapy before the biopsy. Normal control
lung tissues were obtained from the normal areas of lungs
that had been surgically removed from eight patients
because of cancer. Table 1 shows the characteristics of the
nine patients with UIP, eight patients with NSIP, and eight
normal control subjects. In addition to the histologic
diagnosis, we confirmed that the clinical data, pulmonary
function test results, bronchoalveolar lavage findings,
chest radiographic findings, and follow-up information
obtained from the patients were consistent with the diag-
noses. Diagnostic criteria of the American Thoracic Soci-
ety/European Respiratory Society consensus classification
system were applied [30]. We also verified that none of
the patients with UIP had a connective tissue disease. In
the group of patients with NSIP, two with Sjögren's syn-
drome and one with rheumatoid arthritis were included.
In all other cases, no etiologic agent was found. These tis-
sue samples were used for microscopic immunohisto-
chemistry, Western blotting, and Northern blotting
assays. The procedures used in this study were in accord-
ance with those recommended by the regional ethical
committee on human experimentation.
Northern Blotting Studies
Human epimorphin DNA fragments were isolated by
reverse transcriptase-polymerase chain reaction. Strand
cDNA was synthesized with random primers from human
lung total RNA. Polymerase chain reaction assays were
carried out at 95°C for 1 minute, 64°C for 1 minute, and
72°C for 1 minute for 35 cycles. The following primer
pairs were used: human epimorphin forward 5'-GGA ACC
GGA CTT CAG TGG ATC-3' and reverse 5'-CAGC CAA
TGA TTA GAG CCA GGA-3'. Polymerase chain reaction
products were subcloned into the NcoI and SpeI sites ofRespiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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the pGEM-T Vector (Promega, Madison, WI), and authen-
ticity was confirmed by sequencing. Total cellular RNA
was isolated from lung tissues from each case by using the
acid guanidinium-isothiocyanate-phenol-chloroform
method. The RNA samples (10 µg/lane) were fractionated
by electrophoresis on 1% agarose-formaldehyde gels
under denaturing conditions and were transferred to
Nytran by capillary action. The blots were then probed
with the 339-bp NcoI/SpeI fragment of the human epi-
morphin cDNA labeled with [32P]dCTP (3000 Ci/mmol)
by means of the Nick Translation System kit (GIBCO/BRL,
Grand Island, NY). After hybridization, blots were washed
and were processed by autoradiography. Washed blots
were analyzed by using a Fujix BAS2000 Bio-Imaging ana-
lyzer system (BASTM, Fuji Photo Film Co., Ltd., Tokyo,
Japan) and were visualized on Kodak X-OMAT AR film
(Eastman Kodak, Rochester, NY). Signal intensity was
quantified in digital images via BASTM analysis (FUJIX
BAStation, Fuji Photo Film Co., Ltd.). To control for dif-
ferences in gel loading, for each sample the RNA hybrid-
ized with the epimorphin probe was normalized to the
expression of β-actin mRNA in the same sample.
Western Blotting Studies
Although the monoclonal antibody to mouse epimor-
phin (MC-1) has been reported to cross-react with human
epimorphin [31,32], we performed Western blotting to
confirm whether the anti-epimorphin antibody (MC-1, a
gift from Dr. Hirai, Osaka R&D Laboratory (Yokohama-
lab), Sumitomo Electric Industries, Yokohama, Japan)
cross-reacted with the human epimorphin in our lung
samples and to make comparisons of epimorphin peptide
expression between normal and fibrotic groups. For
immunoblotting, lung tissues from each case were dis-
solved in sample buffer containing 2% sodium dodecyl
sulfate in 8 M urea and were kept at 4°C overnight; the
same protein concentration (30 µg) in samples from each
lung extract was ensured by using Protein Assay (Bio-Rad
Laboratories, Hercules, CA). Lung tissues from normal
adult mice were also dissolved in sample buffer as above
and served as positive controls. Those samples were sub-
jected to sodium dodecyl sulfate-polyacrylamide gel elec-
trophoresis according to the method of Laemmli (1970),
and proteins in the gels were transferred onto nitrocellu-
lose filters and were incubated sequentially with 5% skim
milk in 0.5% Tween 20 overnight. Blots were then incu-
bated at 4°C overnight with 10 µg/ml rat anti-mouse epi-
morphin primary monoclonal antibody MC-1 used at a
dilution of 1:1000 in 1% bovine serum albumin. Samples
were then stained by incubation with horseradish peroxi-
dase-conjugated anti-rat goat IgG F(ab')2 antibody (Bio-
source International Inc., Camarillo, CA) used at a
dilution of 1:1000 in Tris-buffered saline with 0.05%
Tween 20 for 2 hours at room temperature. The bound
antibody was detected by using the enhanced chemilumi-
nescence method (Amersham Pharmacia Biotech UK Lim-
ited, Little Chalfont, Buckinghamshire, England)
according to the manufacturer's protocol.
Light Microscopic Immunohistochemistry
A portion of each lung specimen was fixed immediately in
a solution of 4% paraformaldehyde in 0.1 M phosphate
buffer (pH 7.4), after which samples were sequentially
washed for 4 hours in 10% sucrose in 0.01 M phosphate-
buffered saline (pH 7.4, 4°C), 4 hours in 20% sucrose in
phosphate-buffered saline, and overnight in 30% sucrose
in phosphate-buffered saline. They were then snap-frozen
in OCT embedding medium and stored at -80°C.
Frozen tissues were cut into 4-µm sections, which were
incubated for 30 minutes with a biotin blocking system
(Dako Corporation, Carpinteria, CA) and for 30 minutes
with 0.3% hydrogen peroxide in methanol to eliminate
endogenous peroxidase activity. After treatment with nor-
mal goat serum, tissues were incubated overnight at 4°C
with 10 µg/ml rat anti-mouse monoclonal epimorphin
antibody and were then incubated for 1.5 hours at 37°C
with 1 µg/ml biotinylated goat anti-rat IgG (ZYMED, San
Francisco, CA) and streptavidin-biotin-horseradish perox-
idase complex (Dakopatts, Glostrup, Denmark). Bound
antibody was visualized after incubation for 10 minutes
in a Coplin jar with 100 ml of Tris-HCl buffer (pH 7.6)
containing 20 mg of diaminobenzidine and 17 ml of 30%
H2O2. Counterstaining was with Mayer's hematoxylin.
Lung tissue of normal adult mice was stained as a positive
control. Nonspecific labeling of primary antibody was
evaluated with normal rat serum. Each tissue sample was
also stained for keratin (rabbit anti-bovine antibody
raised against the 58-, 56-, and 52-kd subunits of muzzle
epidermal keratin; Dakopatts, Santa Barbara, CA), α-
smooth muscle actin (mouse anti-human α-smooth mus-
cle actin monoclonal antibody; Dakopatts, Santa Barbara,
CA), and MMP-2 (mouse anti-human MMP-2 mono-
clonal antibody; clone 42-5D11, IgG1 isotype, purified
antibody; Daiichi Fine Chemical Co., Ltd., Takaoka,
Japan). Serial sections were also stained with hematoxy-
lin-eosin (H&E) and Alcian blue-periodic acid-Schiff (AB-
PAS).
Confocal Microscopy
To localize epimorphin as precisely as possible, epithelial
and stromal cells were double labeled by means of
immunofluorescent probes, and the distribution of epi-
morphin was compared with that of keratin and vimentin
(mouse monoclonal anti-vimentin [V9] antibody; Dako-
patts, Glostrup, Denmark). Briefly, after sections were
exposed to primary antibodies, they were exposed to sec-
ondary antibodies: for the first analysis: fluorescein isothi-
ocyanate-conjugated goat anti-rat IgG (American Qualex,
San Clemente, CA) or Texas Red-conjugated goat anti-rab-Respiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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bit IgG (Molecular Probes, Inc., Eugene, OR); for the sec-
ond analysis: fluorescein isothiocyanate-conjugated goat
anti-rat IgG (American Qualex) or Texas Red-conjugated
goat anti-mouse IgG (Molecular Probes). The nuclei were
counterstained with 4,6-diamidino-2-phenylindole dihy-
drochloride (Vector Laboratories, Inc., Burlingame, CA).
Specimens were examined under a confocal laser scanning
microscope (TCS-SP; Leica Lasertechnik, Heidelberg, Ger-
many), based on an upright microscope (DMRB, Leica
Lasertechnik) equipped with a krypton/argon laser [33].
The excitation wavelengths for fluorescein isothiocyanate
and Texas Red were 498 nm and 568 nm, respectively.
Green fluorescein isothiocyanate emission was selected
and recorded by using a 500- to 550-nm bandpass filter;
red Texas Red emission was selected and recorded by
using a 581- to 631-nm bandpass filter. In addition, 4,6-
diamidino-2-phenylindole dihydrochloride was excited
at 350-nm by using a UV laser, and its blue emission was
recorded via a 401- to 551-nm bandpass filter.
Localization of MMP-2 and Epimorphin in Lungs with 
NSIP
To compare the precise localization of MMP-2 and epi-
morphin in NSIP, a confocal microscope was used for
immunohistochemical study of lung tissues from patients
with NSIP, by means of the same technical immunohisto-
chemical staining and analysis method as that described
previously for epimorphin and keratin detection [34].
Mouse anti-human MMP-2 monoclonal antibody and rat
anti-mouse monoclonal epimorphin antibody served as
primary antibodies. Secondary antibodies for double-
labeling immunohistochemistry studies via confocal
microscopy were goat anti-mouse IgG antibody (Alexa
Fluor 546; Molecular Probes) and goat anti-rat IgG anti-
body (Alexa Fluor 488; Molecular Probes).
Cell Culture and Treatment Conditions
Human lung-derived alveolar epithelial cells (A549), an
epithelial cell line derived from lung adenocarcinoma
(Cell Resource Center for Biomedical Research, Institute
of Development, Aging and Cancer, Tohoku University),
were cultured in RPMI (GIBCO/BRL) supplemented with
10% fetal bovine serum, 2 mM l-glutamine, 50 U/ml pen-
icillin, and 50 µg/ml streptomycin. All cells were main-
tained at 37°C in a humidified incubator containing 5%
CO2 and 95% air.
Detection of MMP-2 Expression in A549 Cells
Four-well chamber slides (Lab-Tek II, Nalge Nunc Interna-
tional, Naperville, IL) were coated with human recom-
binant epimorphin fragment (H12; 20 µg/well, dissolved
in 1.5 mM HCl; a gift from Dr. Hirai), negative control
solution prepared from non-transfected Escherichia coli
strain BL21 (BL; 20 µg/well, dissolved in 1.5 mM HCl; a
gift from Dr. Hirai), or Type IV collagen from human pla-
centa collagen (20 µg/well, dissolved in 0.4% glacial ace-
tic acid; Sigma Chemical Co., St. Louis, MO), after which
samples were dried at room temperature. After A549 cells
were washed two times with phosphate-buffered saline,
the cells (5 × 105) were suspended in RPMI medium with
2% fetal calf serum and were incubated at 37°C on the
chamber slides coated with recombinant epimorphin, BL,
or Type IV collagen. After incubation for 9 h, culture
dishes were placed on ice, medium from each dish was
collected, and cells were washed twice with phosphate-
buffered saline. Cells were fixed in 4% paraformaldehyde
in phosphate-buffered saline for 5 minutes at -20°C and
then were washed in phosphate-buffered saline and per-
meabilized in acetone for 5 minutes at -20°C. Cells were
again washed in phosphate-buffered saline and incubated
with a blocking solution containing 1% bovine serum
albumin/phosphate-buffered saline for 1 hour at room
temperature. Immunohistochemistry was performed via
the same technical method described above for epimor-
phin detection. The primary antibody was 5 µg/ml mouse
anti-human MMP-2 monoclonal antibody, and the sec-
ondary antibody was horseradish peroxidase-conjugated
goat anti-mouse IgG antibody (Amersham Pharmacia
Biotech UK Limited).
The A549 culture supernatant collected after incubation
for 9 hours on the chamber slides coated with recom-
binant epimorphin, BL, and Type IV collagen was used to
determine the amount of MMP-2 activity by means of the
MMP-2 Biotrack Activity Assay System (Amersham Phar-
macia Biotech UK Limited), according to the manufac-
turer's instructions. All samples were assayed in triplicate,
and assays were repeated three times.
Statistical Analysis
Densitometric analysis of the bands of Northern and
Western blotting was performed with Macintosh G4 com-
puter (Apple Japan, Inc., Tokyo, Japan) using high-resolu-
tion scanner and NIH image software (version 1.62,
National Institutes of Health, Bethesda, Maryland). The
data are expressed as a ratio of a standard normal control
subject to each case's band density units (arbitrary units)
and reported as mean ± standard error of the mean (SEM).
Statistical significance was established using the one-way
analysis of variance test followed by Tukey-Kramer multi-
ple intergroup comparison test. Probabilities less than
0.05 were considered significant.
Results
Expression of Epimorphin mRNA in Normal Human Lungs 
and Lungs of Patients with NSIP or UIP
Expression of 3.2-kb epimorphin mRNA was revealed in
all lung samples from patients with NSIP, UIP and normal
control subjects by Northern blotting (Figure 1A). To con-
firm that the blots reflected samples of equal size, theyRespiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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were reprobed for expression of β-actin mRNA. Compared
with corresponding densities of β-actin, the densities of
epimorphin expression in NSIP samples were signifi-
cantly higher than those in control lungs and lungs with
UIP, as determined by NIH Image analysis (P < 0.05) (Fig-
ure 1B).
Tissue Localization of Epimorphin in Normal Human 
Lungs
Western blotting showed that rat anti-mouse epimorphin
monoclonal antibody (MC-1) recognized the 150-kd
bands in the extracted samples from both mouse lung and
normal human lung (Figure 2A), similar to results
reported elsewhere [31,32]. We thus confirmed that anti-
mouse epimorphin antibody demonstrated specificity
and cross-reactivity with the human epimorphin of our
lung samples. Normal lung tissues of the human samples
had normally opened alveoli with infiltration of a few
inflammatory cells. In immunohistochemical studies of
the human samples, as with normal mouse lung speci-
mens [34], epimorphin was weakly stained in vascular
and alveolar walls (Figure 2B). Negative control staining
with normal rat serum showed no positive findings in the
serial section (data not shown).
Amount of Epimorphin in Normal Human Lungs and Lungs 
of Patients with NSIP or UIP
In the lung tissue homogenates of patients with NSIP, UIP
and of control subjects, Western blotting with antibody
for epimorphin also recognized the 150-kd bands (Figure
3A) and the densities of the bands of patients with NSIP
are relatively higher than those of UIP and control sub-
jects by methods of NIH image analysis (p < 0.05) (Figure
3B).
(A) Representative Northern blots of epimorphin mRNA and  β-actin mRNA Figure 1
(A) Representative Northern blots of epimorphin mRNA and 
β-actin mRNA. Epimorphin mRNA (3.2-kb) was expressed in 
samples of normal lung (Control: lanes 1–3) and lungs from 
patients with UIP (lanes 4–6) and patients with NSIP (lanes 7–
9) (upper blot). To confirm that the blots reflected samples of 
equal size, they were reprobed for expression of β-actin 
mRNA (lower blot). (B) The data are expressed as a ratio of 
epimorphin to β-actin band density units (arbitrary units) and 
reported as mean ± SEM measured by means of NIH Image 
analysis. In NSIP samples, the density of epimorphin expres-
sion was significantly higher than that in control and UIP sam-
ples (*P < 0.05).
Representative Western blots for epimorphin in normal  mouse and human lung samples (A), and representative epi- morphin immunohistochemistry (B) in normal mouse lung Figure 2
Representative Western blots for epimorphin in normal 
mouse and human lung samples (A), and representative epi-
morphin immunohistochemistry (B) in normal mouse lung. 
(A) Recognition of the 150-kd bands by rat anti-mouse epi-
morphin monoclonal antibody (MC-1) in extracted lung sam-
ples. (B) Weak epimorphin staining in vascular walls 
(arrowheads) and alveolar walls (inset). Scale bar = 50 µm.Respiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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Tissue Localization of Epimorphin in NSIP and UIP by 
Means of Immunohistochemical Analyses
In lungs of all patients with NSIP, alveolar walls were
thickened with edema, fibrosis, and inflammatory cell
infiltration; the appearance was typically uniform (Figure
4A). There was slight or no dense fibrosis; intra-alveolar
organizing fibrosis was seen as pale eosinophilic fibrosis
with H&E staining and as Alcian blue positive area with
AB-PAS staining as early stage of fibrosis (Figure 4A and
4B). Epimorphin immunostaining was strong in the early
intra-alveolar fibrotic areas with a covering of regenerated
alveolar epithelial cells (Figure 4C and 4E), which con-
tained a few α-smooth muscle actin-positive cells (Figure
4F), in addition to immunostaining seen in vascular and
alveolar walls. No positive findings was shown using nor-
mal rat serum as fist antibody for negative control (Figure
4D). The epimorphin immunohistochemical staining pat-
terns for all eight patients with NSIP were quite similar.
In lungs of all patients with UIP, the fibrotic zones
showed temporal heterogeneity, with dense acellular col-
lagen and scattered fibroblastic foci with intervening
nearly normal alveoli. Most fibrotic zones had honey-
combing with complete destruction of the architecture
(Figure 5A). Though clear immunostaining in the vascular
walls, only weak epimorphin immunostaining occurred
in dense fibrotic lesions and scattered fibroblastic foci, as
in areas of early fibrosis (Figure 5B and 5F) with Alcian
blue positive (Figure 5E). The scattered fibroblastic foci
contained many α-smooth muscle actin-positive cells
(Figure 5D) with the desquamative regenerated alveolar
(A) Representative Western blots for epimorphin in normal  control subjects and fibrotic groups Figure 3
(A) Representative Western blots for epimorphin in normal 
control subjects and fibrotic groups. Epimorphin protein 
(150-kd) was expressed in samples of normal lung (Control: 
lanes 1–3) and lungs from patients with UIP (lanes 4–7) and 
patients with NSIP (lanes 8–10). (B) The data are expressed 
as a ratio of a standard normal control subject to each case's 
band density units (arbitrary units) and reported as mean ± 
SEM measured by means of NIH Image analysis. In NSIP sam-
ples, the density of epimorphin protein expression was signif-
icantly higher than that in control and UIP samples (*P < 
0.05)
Representative histology stained with hematoxylin-eosin  (H&E) (A) and Alcian blue-periodic acid-Schiff (AB-PAS) (B)  and immunohistochemistry for epimorphin (C), rat normal  serum as negative control for epimorphin (D), keratin (E),  and α-smooth muscle actin (F) for all patients with NSIP Figure 4
Representative histology stained with hematoxylin-eosin 
(H&E)(A) and Alcian blue-periodic acid-Schiff (AB-PAS)(B) 
and immunohistochemistry for epimorphin (C), rat normal 
serum as negative control for epimorphin (D), keratin (E), 
and α-smooth muscle actin (F) for all patients with NSIP. (A) 
Thickened alveolar walls showed edema, fibrosis, and inflam-
matory cell infiltration. Dense fibrosis was inconspicuous or 
absent. (A and B) Intra-alveolar organizing fibrotic areas were 
seen as pale eosinophilic fibrosis with H&E staining and as 
Alcian blue positive area with AB-PAS staining as early stage 
of fibrosis (asterisks). (C) Positive epimorphin immunostaining 
appeared in areas of early fibrosis (inset in C shows a close-
up view; asterisks indicates early intra-alveolar fibrotic area) 
covered with regenerated alveolar epithelial cells (arrowhead 
in E), in addition to the alveolar walls. A few α-smooth mus-
cle actin-positive cells were noted in the fibrotic areas (arrow-
head in F). Scale bars = 60 µm.Respiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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epithelial cells overlying these fibroblastic foci (Figure
5C).
Tissue Localization of Epimorphin in NSIP by Means of 
Double-labeled Immunohistochemical Analyses
Double-labeled confocal fluorescent images confirmed
the presence of epimorphin in early fibrotic lesions and
keratin-positive epithelial cells overlying the lesions (Fig-
ure 6A and 6B). Double-labeled confocal fluorescent
images also verified the localization of epimorphin in
vimentin-positive stromal cells and in surrounding ECM
(Figure 6C, D, and 6E) in early fibrotic lesions.
Localization of MMP-2 and Its Relation to Epimorphin in 
NSIP
Areas of early fibrosis in lung tissues from patients with
NSIP showed epimorphin immunoreactivity (Figure 7A),
and regenerating epithelial cells overlying these lesions
demonstrated MMP-2 labeling (Figure 7B). Furthermore,
in tissues from patients with NSIP, double-labeled confo-
cal fluorescent images confirmed the expression of MMP-
2 (Figure 7C) in re-epithelialized cells overlying fibrotic
lesions in which epimorphin was also clearly expressed.
Increased Expression of MMP-2 Induced in A549 Cells by 
Epimorphin
Nine hours after plating of BL or Type IV collagen-coated
chamber slides with cells of the human lung-derived alve-
olar epithelial cell line A549, the cells had spread and
formed a loose sheet (Figure 8A, left panel). However,
during the same time period, in recombinant epimor-
phin-coated chamber slides, the A549 cells formed some
monolayer cell islands in addition to the loose cellular
sheet, in about 50% of the chamber slide area (Figure 8A,
right panel). Moreover, the immunoperoxidase method
Representative histology (A, C [close-up view]; H&E staining)  and immunohistochemistry for epimorphin (B, F [close-up  view]) and α-smooth muscle actin (D [close-up view]) of  scattered fibroblastic foci in early fibrotic areas as Alcian blue  positive area (E; AB-PAS staining) for patients with UIP Figure 5
Representative histology (A, C [close-up view]; H&E staining) 
and immunohistochemistry for epimorphin (B, F [close-up 
view]) and α-smooth muscle actin (D [close-up view]) of 
scattered fibroblastic foci in early fibrotic areas as Alcian blue 
positive area (E; AB-PAS staining) for patients with UIP. (A 
and C) Honeycombing with complete architectural destruc-
tion occurred in fibrotic zones. (C and E) Arrowheads indi-
cate scattered fibroblastic foci. In addition to clear 
immunostaining in the vascular and alveolar walls (arrows), 
only weak epimorphin immunostaining was seen in scattered 
fibroblastic foci (arrowheads) (B and F); many α-smooth mus-
cle actin-positive cells (D) and desquamative regenerated 
alveolar epithelial cells (C) were found. Scale bars = A, B: 200 
µm; C–E: 80 µm.
Representative double-labeled confocal fluorescent images of  staining for epimorphin plus keratin (A), epimorphin (C),  vimentin (D), and epimorphin plus vimentin (E) in an early  fibrotic lesion from the lung of a patient with NSIP Figure 6
Representative double-labeled confocal fluorescent images of 
staining for epimorphin plus keratin (A), epimorphin (C), 
vimentin (D), and epimorphin plus vimentin (E) in an early 
fibrotic lesion from the lung of a patient with NSIP. (A) The 
presence of epimorphin (green) in areas of early fibrosis and 
the presence of keratin (red) in epithelial cells overlying the 
lesions were confirmed. (B) The same image shown in part A 
but with Nomarski optics used. (C–E) Epimorphin (C, green) 
localized in vimentin-positive (D, red) stromal cells (yellow-
orange) and in surrounding ECM in early fibrotic areas (E). 
Nuclei were 4,6-diamidino-2-phenylindole dihydrochloride-
positive (blue). Asterisks indicate early fibrotic areas. Scale 
bars = B: 20 µm, E: 5 µm.Respiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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revealed strong MMP-2 immunostaining in cells of these
cell islands in epimorphin-coated slides after 9 hours of
incubation (Figure 8A, right panel). The MMP-2 Biotrack
Activity Assay System revealed significantly higher MMP-
2 activity levels in the supernatants of cultures of A549
cells with recombinant epimorphin compared with those
for cultures with BL or Type IV collagen after 9 hours of
incubation (Figure 8B).
Discussion
This is the first study to examine in detail the distribution
and magnitude of epimorphin expression in normal
human lungs and lungs from patients with NSIP or UIP.
We found clear expression of epimorphin mRNA and pro-
tein in lung samples from normal control subjects and
patients with NSIP or UIP.
Expression of Epimorphin in Normal Human Lungs
Consistent with previous reports [32], epimorphin was
expressed in connective tissue components of walls of the
alveoli and blood vessels in normal lungs, as determined
by immunohistochemistry. Epimorphin expression was
also confirmed at the mRNA and protein levels by North-
ern and Western blotting assays, similar to results found
previously for mice [15,32]. Although the specific func-
tion of epimorphin in normal lungs is not yet known, it
may serve as an epithelial and endothelial cell morphogen
to maintain the cell turnover necessary for normal struc-
ture and function. Alveolar epithelial cells are replaced at
regular intervals under physiologic conditions. For exam-
ple, the estimated turnover time for normal mouse alveo-
lar epithelial cells ranges from 28 to 35 days [35], and
daily endothelial cell turnover is reported to be about 1%
[36]. Also, in the normal adult human kidney, similar to
results for normal adult mouse kidney, low levels of epi-
morphin mRNA and protein were detected in the glomer-
ular mesangium and peritubular interstitium (interstitial
fibroblast-like cells), as revealed by reverse transcriptase -
polymerase chain reaction and immunohistochemistry
[37]. These findings are consistent with our result that epi-
morphin is expressed in the interstitium in human control
lungs, as in normal adult mouse lungs [34].
Expression of Epimorphin in Lungs of Patients with NSIP or 
UIP
We found, by means of Northern blotting assays, distinct
expression of epimorphin mRNA and protein in normal
Representative images of immunostaining for epimorphin (A)  and MMP-2 (B) in NSIP; the double-labeled confocal fluores- cent image of in an early fibrotic lesion from the lung of a  patient with NSIP was stained for epimorphin plus MMP-2  (C) Figure 7
Representative images of immunostaining for epimorphin (A) 
and MMP-2 (B) in NSIP; the double-labeled confocal fluores-
cent image of in an early fibrotic lesion from the lung of a 
patient with NSIP was stained for epimorphin plus MMP-2 
(C). (A) Epimorphin immunoreactivity was observed in early 
fibrotic areas, with (B) MMP-2 labeled in regenerated epithe-
lial cells overlying the fibrotic lesion. Asterisks indicate early 
fibrotic areas. (C) MMP-2 (red) was strongly expressed in re-
epithelialized cells overlying early fibrotic lesions with clear 
epimorphin expression (green). Nuclei were 4,6-diamidino-
2-phenylindole dihydrochloride-positive (blue). Asterisks 
indicate early fibrotic areas. Scale bars = 20 µm.
(A) Representative images of MMP-2 immunostaining in A549  cells cultured with recombinant epimorphin (right panel) or  with BL (left panel) after 9 hours of incubation Figure 8
(A) Representative images of MMP-2 immunostaining in A549 
cells cultured with recombinant epimorphin (right panel) or 
with BL (left panel) after 9 hours of incubation. In the epimor-
phin-coated slides, plated cells formed some monolayer cell 
islands in addition to loose sheets of cells, and cells in these 
cell islands showed strong MMP-2 immunostaining (by the 
immunoperoxidase method). Scale bars = 30 µm. (B) Via the 
MMP-2 Biotrack Activity Assay System, MMP-2 activity in the 
supernatants of A549 cells cultured with recombinant epi-
morphin was higher than in supernatants of cells cultured 
with BL or Type IV collagen (P = 0.01).Respiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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lungs and lung samples of patients with NSIP or UIP, with
significantly higher epimorphin expression in lungs of
patients with NSIP than in other lung samples. Also, serial
sections and double-labeled immunohistochemistry anal-
yses of NSIP samples demonstrated strong expression of
epimorphin in mesenchymal cells situated within active
intra-alveolar fibrotic lesions and the presence of epimor-
phin in the ECM in the vicinity of these cells. These find-
ings are consistent with our previous report that
epimorphin was synthesized by mesenchymal cells and
localized to these cells and the ECM of early intra-alveolar
fibrotic lesions in a murine bleomycin-induced
pulmonary fibrosis model [34]. They are also consistent
with a report that epimorphin was synthesized by normal
human skin fibroblasts [38].
It is well known that regeneration of alveolar and bronchi-
olar epithelial cells is crucial for repair of pulmonary
fibrosis, and the ECM in early fibrotic lesions provides
fibronectin and other adhesion molecules as ligands for
regenerating epithelial cells to ensure successful repair
[3,4,39-41]. In the murine bleomycin-induced pulmo-
nary fibrosis model, we suggested that epimorphin in the
early fibrotic lesions participated in adhesion of the regen-
erating alveolar epithelial cells. Involvement of epimor-
phin in the repair process was also reported for other
organs including the gut during tissue repair in an isograft
in rats [20] and the liver during regeneration after partial
hepatectomy in mice [17]. Increased expression of epi-
morphin during epithelial cell regeneration was also
reported in human skin ulcers and active ulcerative colitis
[32,42].
We observed strong epimorphin immunostaining in early
fibrotic areas with a few α-smooth muscle actin-positive
cells in NSIP, as well as weak epimorphin immunostain-
ing in fibroblastic foci with many α-smooth muscle actin-
positive cells and desquamative regenerated alveolar epi-
thelial cells in UIP. It is believed that in UIP, a failure of
re-epithelialization of fibroblastic foci maintains fibrob-
last/myofibroblast activity and ECM synthesis [43,44]. We
suggest that highly expressed epimorphin in the lungs of
patients with NSIP may be necessary during wound heal-
ing, especially for regeneration of alveolar epithelial cells
in early fibrotic lesions, and we also suggest that poorly
expressed epimorphin in the lungs of patients with UIP
may lead to failure of re-epithelialization of fibroblastic
foci and the contraction of fibrotic lungs during the end
stage of UIP.
Role of Epimorphin Associated with MMP-2 in Lung 
Repair
To understand the role of epimorphin in the repair proc-
ess in the lungs of patients with NSIP, we evaluated
whether epimorphin enhanced expression of MMP-2
(gelatinase A). Recombinant epimorphin induced forma-
tion of some monolayer cell islands in addition to a loose
cellular sheet and augmented expression of MMP-2 in cul-
tured human alveolar epithelial cells, as demonstrated by
immunohistochemistry and the MMP-2 Activity Assay
System. We suggest that epimorphin-induced monolayer
cell islands are a type of formation of differentiated alveo-
lar epithelial cells, like the epimorphin-induced spheroid
formation of rat hepatocytes, and suggest that the
augmented expression of MMP-2 may be similar to the
increased albumin production of rat hepatocytes.
We also demonstrated expression of MMP-2 in re-epithe-
lialized cells overlying epimorphin-positive early fibrotic
areas by means of double-labeled confocal fluorescent
images. MMP-2, which is an important proteinase needed
for matrix degradation, is secreted by type II alveolar epi-
thelial cells in vitro [45]. Fukuda et al. [25] observed the
localization of MMP-2 in fetal rabbit alveolar epithelial
cells and gelatinolytic activities of MMP-2 in fetal rabbit
lung, which indicated an important role for MMP-2 in for-
mation of alveoli. These authors also observed the locali-
zation of MMP-2 in regenerating alveolar epithelial cells
covering intra-alveolar fibrotic areas in a study of bronchi-
olitis obliterans organizing pneumonia, which is a revers-
ible fibrotic human lung disease [13]. Yaguchi et al. [26]
reported that MMP-2 was found in regenerating alveolar
epithelial cells and that gelatinolytic activities of the active
forms of MMP-2 increased in later repair stages in
bleomycin-induced pulmonary fibrosis, during recon-
struction of alveoli. Moreover, Fukuda et al. [46] reported
that in bleomycin-induced pulmonary fibrosis, re-epithe-
lialization on the surface of early intra-alveolar fibrotic
lesions in gelatinase A-/- mice was markedly reduced com-
pared with that of gelatinase A+/+ controls. Thus, MMP-2
was up-regulated and activated in regenerating alveolar
epithelial cells, which may allow elongation and migra-
tion of these cells for successful repair of pulmonary
fibrotic lesions [[26,27], 47].
We therefore suggest that epimorphin expression in early
fibrotic lesions in the lungs of patients with NSIP may
contribute to the repair process in pulmonary fibrosis, in
part by inducing MMP-2 expression. What may follow
this MMP-2 expression may be elongation and migration
of regenerating epithelial cells and degradation of ECM in
alveolar spaces. Thus, epimorphin, as a component of
proteolytic systems, may contribute to cell migration and
tissue remodeling during repair of human lung fibrosis.
Although epimorphin receptors have not yet been identi-
fied, binding ECM molecules has been suggested as
involved in establishing epithelial polarity, thus helping
form an organized basement membrane and cell-ECM
junctional complexes [21]. Our results are consistent withRespiratory Research 2005, 6:6 http://respiratory-research.com/content/6/1/6
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the idea [22,34] that epimorphin has a high affinity for
ECM molecules and could modify functions of adhesion
and migration of regenerating alveolar epithelial cells by
altering signaling through MMP-2.
In conclusion, epimorphin expressed in lungs may have
important roles as a morphogen not only in mice but also
in humans, and epimorphin may contribute to the repair
process in human pulmonary fibrosis via epithelium-mes-
enchyme interactions.
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